Anti-Carboxypeptidase-O Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of the catalytic domain of human Carboxypeptidase-O, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
Q8IVL8
Size
100ug
Cat. #
RP3CarboxypeptidaseO

In stock

SKU
RP-CarboxypeptidaseO

Options

As low as: $130.00

Target Overview

Carboxypeptidase-O (CPO, EC 3.4.17.-, UniProt Q8IVL8) is a membrane-associated metallocarboxypeptidase that catalyzes the removal of C-terminal amino acids from peptide and protein substrates. The enzyme exhibits preferential activity toward acidic residues at the C-terminus, though it can also cleave hydrophobic residues with a bias for smaller side chains over bulkier ones. CPO localizes to the apical cell membrane, where it is positioned to process extracellular or luminal substrates. As a member of the M14 family of zinc-dependent carboxypeptidases, CPO shares structural features with related enzymes but displays distinct substrate specificity. The 374-amino-acid protein contains a catalytic domain responsible for its exopeptidase activity. Researchers study CPO in contexts ranging from peptide metabolism and protein maturation to cell surface signaling events. Its restricted substrate preference and apical localization suggest roles in tissue-specific proteolytic pathways, though the full spectrum of physiological substrates remains an active area of investigation.

Background

Carboxypeptidases constitute a diverse enzyme family responsible for sequential removal of amino acids from the C-terminus of polypeptide chains. Within this family, CPO represents a less-studied member whose biological roles are still being defined. The enzyme's preference for acidic C-terminal residues distinguishes it from carboxypeptidases A and B, which favor hydrophobic and basic residues, respectively. This specificity implies that CPO processes a distinct subset of peptide and protein substrates in vivo. The apical membrane localization of CPO positions it at interfaces between cells and their external environment, including luminal spaces in epithelial tissues, where it may regulate peptide signaling, hormone processing, or extracellular matrix remodeling. Recent work has begun to implicate carboxypeptidases and related metalloproteinases in developmental and pathological processes. Capecki et al. (2026) demonstrated that disruption of the discoidin domain receptor 2 contributes to palate malformations through effects on extracellular matrix composition, highlighting the importance of coordinated proteolytic processing in craniofacial development. While CPO was not the focus of that study, such findings underscore the broader relevance of metalloproteinase pathways in tissue morphogenesis and matrix remodeling. Understanding the substrate repertoire and regulatory mechanisms governing CPO activity will help clarify its contributions to normal physiology and disease states. Triple Point Biologics offers three rabbit polyclonal antibodies targeting Carboxypeptidase-O, raised against the amino-terminal region of the catalytic domain. These reagents have been validated for Western blot, providing researchers with tools to investigate CPO expression, localization, and regulation across experimental systems.

References

  1. Capecki JA et al (2026) Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix. Hum Mol Genet. PubMed · DOI

Additional Specifications

Gene Symbol CPO
UniProt ID Q8IVL8
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (amino end of the catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 49-89.
Immunogen (carboxy end of the catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 304-344.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 302-352.
Alternate Names CPO, Carboxypeptidase O, EC 3.4.17.-

Frequently Asked Questions

What molecular weight band should I expect for Carboxypeptidase-O on Western blot?

The predicted molecular weight for full-length human Carboxypeptidase-O is approximately 42 kDa based on the 374-amino-acid sequence. Because CPO is a membrane-associated protein, you may observe additional higher-MW bands if post-translational modifications such as glycosylation are present in your sample. Running a positive control lysate from tissue or cells known to express CPO at the apical membrane will help confirm the expected migration pattern in your gel system. If you see multiple bands, consider whether your sample preparation retained membrane-associated forms versus soluble processed fragments.

What starting dilution should I use for Western blot with this CPO antibody?

We recommend starting at 1:1000 for Western blot, which has been validated with this antibody. Depending on CPO expression levels in your sample and your detection system sensitivity, you may need to optimize between 1:500 and 1:2000. Because CPO is a membrane protein with tissue-restricted expression patterns, samples with low endogenous CPO may require higher antibody concentration or longer exposure times. Always include a known positive control lysate to distinguish true signal from background, and consider membrane enrichment during sample preparation to improve detection.

Is this Carboxypeptidase-O antibody likely to cross-react with mouse or rat samples?

This antibody is validated for human CPO. Cross-reactivity with mouse or rat is predicted based on sequence homology but has not been experimentally validated. Human CPO shares significant conservation with rodent orthologs in the catalytic domain, so cross-reactivity is plausible. If you are working with mouse or rat samples, plan to empirically test the antibody at the recommended dilution range alongside a human positive control. Assess band patterns carefully, as non-specific binding can complicate interpretation without validated positive controls in your species of interest.

Can I use this antibody for immunofluorescence to detect CPO at the apical membrane?

Yes, Triple Point Biologics antibodies are validated for immunofluorescence applications. Because CPO localizes to the apical cell membrane, proper sample preparation is critical. Use polarized epithelial cell models or tissue sections where apical domains are accessible. Ensure adequate permeabilization if detecting intracellular pools, though surface staining of non-permeabilized cells may work for apical CPO. Start with a dilution around 1:100 to 1:200 for IF and optimize based on signal intensity. Include cells or tissue with minimal CPO expression as a negative control to assess specificity of membrane staining.

What positive control tissue should I use for Carboxypeptidase-O Western blot?

CPO expression is enriched in tissues where apical membrane processing of peptides occurs, including kidney and intestinal epithelium. Kidney lysate is a practical positive control, as CPO participates in renal peptide processing. If you are studying CPO in a specific context, consider using lysate from polarized epithelial cell lines known to express CPO or tissue samples relevant to your research question. Membrane-enriched fractions will yield stronger signal than whole-cell lysates due to CPO's membrane association. Document your positive control source for reproducibility across experiments.

Does Carboxypeptidase-O have multiple isoforms I should be aware of on a blot?

Human CPO is encoded by a single gene, and the primary translated product is 374 amino acids. Alternative splicing has not been widely reported for CPO, so you should typically observe one major band corresponding to the full-length protein. However, membrane proteases can undergo proteolytic processing, and post-translational modifications may cause mobility shifts. If you observe multiple bands, consider whether your sample contains proteolytic fragments, differentially modified forms, or non-specific binding. Running samples with and without reducing agents can help distinguish disulfide-linked aggregates from monomeric CPO.

How should I store this antibody and how long will it remain stable?

Store the antibody at –20°C as per standard practice for polyclonal antibodies. Avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. For frequent use, consider preparing small aliquots at the first thaw. The antibody should remain stable for at least 12 months when stored properly at –20°C. If you notice decreased signal or increased background over time, this may indicate antibody degradation or contamination. Adding sodium azide to a final concentration of 0.02 to 0.05 percent can extend shelf life for liquid aliquots stored at 4°C for short-term use.

What sample prep considerations are important for detecting membrane-associated CPO?

Because CPO is a membrane-associated metallocarboxypeptidase, sample preparation significantly affects detection efficiency. Whole-cell lysates will contain CPO, but membrane-enriched fractions improve signal strength. Use lysis buffers containing non-ionic detergents such as Triton X-100 or NP-40 at 0.5 to 1 percent to solubilize membrane proteins effectively. Avoid harsh detergents like SDS during lysis, as these can denature CPO and complicate detection. Include protease inhibitors to prevent degradation during sample handling. If CPO is your target, sonication or mechanical disruption combined with detergent extraction yields better results than detergent alone.

Validation imagery coming soon

Western blot validation figures for RP-CarboxypeptidaseO will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • CPO
  • Carboxypeptidase O
  • EC 3.4.17.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →